Delivery Order SPE2DB20D3103-SPE2DB23FN4J1
Award Date
5/17/23
Potential Completion Date
6/8/23
Potential Value
$70K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,355.67, is for the provision of JEMPERLI 500 MG/10 ML VIAL 10ML, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,903.78, is a Firm Fixed Price Delivery Order for the JEMPERLI 500 MG/10 ML VIAL 10ML pharmaceutical product. The contract has an ultimate completion date of April 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JEMPERLI 500 MG/10 ML VIAL 10ML. The contract has a ceiling value of $22,355.67 and a period of performance through March 28, 2025. It is a firm-fixed-price contract type. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DX15D2100|SPE2DX24F33WK, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,112.76 firm fixed-price delivery order is for the pharmaceutical product JEMPERLI 500 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of February 8, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $34,009.17 firm fixed-price contract is for the supply of the prescription drug JEMPERLI 500 MG/10 ML VIAL 10ML. There is no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, worth $1,968.92, is a Firm Fixed Price Delivery Order for the medical product "MOUNJARO 10 MG/0.5 ML PEN 0.5ML". The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,700.71, is a delivery order for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of June 21, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $17,893.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the provision of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through May 1, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $13,083.48 Firm Fixed Price Delivery Order is for the pharmaceutical product TREMFYA 100 MG/ML SYRINGEML, with a completion date of November 13, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award, valued at $11,095.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of TREMFYA 100 MG/ML SYRINGEML, a medical product. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...